Skip to main content

Dr. Erin Heinzen Renews R01 from NINDS

June 30, 2023

Erin Heinzen, PharmD, PhD, was awarded a renewal of her R01 grant titled “Identification and molecular characterization of somatic mutations in MCD” from NINDS.